Skip to main content

27.02.2024 | Letter to the Editor

Serotonin deficiency and psychiatric long COVID: both caused specifically by the virus itself or an adaptive general stress response?

verfasst von: Udo Bonnet, Jens Kuhn

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience

Einloggen, um Zugang zu erhalten

Excerpt

Infections with the COVID-19 virus and its aftermath, the long COVID syndrome, are far from being understood considering their underlying biological and psychological mechanisms [1]. In this context, antidepressants with serotonergic actions have been increasingly examined and discussed as to whether they can influence the course and severity of COVID-19 [2, 3] and presumably, long COVID too (with regard to long COVID, see Table 1). Postulated mechanisms include an attenuation of an overshooting pro-inflammatory response on cellular virus entry as well as direct antiviral effects [2, 3]. A recent publication in Cell seems to shed more light on this enigma [4]. Wong et al. found reduced plasma serotonin levels in mice infected with SARS-CoV2 as well as in a small clinical cohort of patients seeking treatment for long COVID. Interestingly, reduced plasma serotonin occurred also during the acute infection period, but not in people who were fully recovered after COVID-19 [4]. Although serotonin plasma levels, which are themselves in large parts dependent on the gut microbiota, do not automatically reflect the situation in brain compartments, a recent finding should be outlined in this context. Richter et al. demonstrated by transcranial sonography that the raphe nuclei of patients with long COVID depression were characterized by a hypo-echogenicity suggesting a dysfunction of the cerebral serotonergic system [5]. A bridge between gut microbiota peripheral and central serotonin levels is mediated by the vagal tone, which is low at depressive conditions corresponding to low serotonin levels [4, 6]. At this juncture, it should be furthermore outlined that beyond depression and anxiety symptoms, an acquired as well as a constitutive serotonin deficiency might account for altered memory and hippocampal synaptic plasticity [4, 7], which could explain also some tenacious cognitive symptoms of long COVID including executive dysfunctions. Taken together, there is increasing evidence that cerebral serotonergic dysfunctions could be responsible for psychiatric COVID-19 sequelae. However, are these dysfunctions really caused by the virus itself, e.g., initiated by dropping peripheral serotonin levels as Wong et al. suggested [4]? Preliminary results describe a missing prevention of long COVID by SARS-CoV2-specific antivirals. Vice versa, cases have been identified with symptoms assigned to long COVID, but without a history for SARS-CoV2 infection [8]. These findings cannot support the viral genesis of behavioral long COVID symptoms. At this point, we emphasize that long COVID covers a number of of behavioral features of a common chronic stress response, which itself is also significantly related to a decrease in serotonin neurotransmission [9] and suggested to activate pro-inflammatory states. At the moment, it is not ruled out that the circumstances around, and negative expectations toward, the virus infection, are more responsible for psychiatric long COVID symptoms (or post-viral symptoms in general) than the specific virus itself.
Table 1
Brief overview of clinical studies testing the effectiveness/efficacy of antidepressants (AD) on long COVID (as of 11/11/2023 found in PubMed; https://​pubmed.​ncbi.​nlm.​nih.​gov/​)
Meta-analysis
Placebo-controlled randomized studies
Prospective studies
Retrospective studies and case series
Long COVID* (mainly brain fog/fatigue, sensory overload, dysautonomia, and anxiety/depression)
None
0
Fluvoxamine (2 × 50 mg)**
 + 
Vortioxetine
 + 
Tricyclic AD (2 Cases)
 
 + 
Fluoxetine (regarding fatigue)
 + 
Antidepressants
 + 
SSRI/SNRI (N = 95)
     
 + 
SSRI (N = 17,933)
*In accordance with the definition of the WHO, we did not separate long COVID from post-COVID. Long COVID is defined “as the continuation or development of new symptoms 3 months after the initial SARS-CoV-2 infection, with these symptoms lasting for at least 2 months with no other explanation” (WHO 2022)
**The tested fluvoxamine dose is suggested to be too low to effectively reduce the development and severity of COVID-19, as one key predictor of long COVID
 +  = reduction of the long COVID morbidity (measured, e.g., by the hospitalization rate)
0 = no significant influence on the long COVID morbidity
AD antidepressants; SSRI selective serotonin re-uptake Inhibitors; SNRI serotonin and noradrenaline re-uptake inhibitors (mainly venlafaxine)
Literatur
1.
2.
Zurück zum Zitat Hoertel N, Sánchez-Rico M, Cougoule C et al (2021) Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms. Mol Psychiatry 26(12):7098–7099CrossRefPubMedPubMedCentral Hoertel N, Sánchez-Rico M, Cougoule C et al (2021) Repurposing antidepressants inhibiting the sphingomyelinase acid/ceramide system against COVID-19: current evidence and potential mechanisms. Mol Psychiatry 26(12):7098–7099CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Bonnet U, Juckel G (2022) COVID-19 outcomes: does the use of psychotropic drugs make a difference? Accumulating evidence of a beneficial effect of antidepressants-A scoping review. J Clin Psychopharmacol 42(3):284–292CrossRefPubMedPubMedCentral Bonnet U, Juckel G (2022) COVID-19 outcomes: does the use of psychotropic drugs make a difference? Accumulating evidence of a beneficial effect of antidepressants-A scoping review. J Clin Psychopharmacol 42(3):284–292CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Wong AC, Devason AS, Umana IC et al (2023) Serotonin reduction in post-acute sequelae of viral infection. Cell 186(22):4851-4867.e20CrossRefPubMed Wong AC, Devason AS, Umana IC et al (2023) Serotonin reduction in post-acute sequelae of viral infection. Cell 186(22):4851-4867.e20CrossRefPubMed
5.
Zurück zum Zitat Richter D, Schulze H, James JC et al (2022) Hypoechogenicity of brainstem raphe in long-COVID syndrome-less common but independently associated with depressive symptoms: a cross-sectional study. J Neurol 269(9):4604–4610CrossRefPubMedPubMedCentral Richter D, Schulze H, James JC et al (2022) Hypoechogenicity of brainstem raphe in long-COVID syndrome-less common but independently associated with depressive symptoms: a cross-sectional study. J Neurol 269(9):4604–4610CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Tan C, Yan Q, Ma Y, Fang J, Yang Y (2022) Recognizing the role of the vagus nerve in depression from microbiota-gut brain axis. Front Neurol 13:1015175CrossRefPubMedPubMedCentral Tan C, Yan Q, Ma Y, Fang J, Yang Y (2022) Recognizing the role of the vagus nerve in depression from microbiota-gut brain axis. Front Neurol 13:1015175CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Fernandez SP, Muzerelle A, Scotto-Lomassese S et al (2017) Constitutive and acquired serotonin deficiency alters memory and hippocampal synaptic plasticity. Neuropsychopharmacology 42(2):512–523CrossRefPubMed Fernandez SP, Muzerelle A, Scotto-Lomassese S et al (2017) Constitutive and acquired serotonin deficiency alters memory and hippocampal synaptic plasticity. Neuropsychopharmacology 42(2):512–523CrossRefPubMed
8.
Zurück zum Zitat Matta J, Wiernik E, Robineau O et al (2022) Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern Med 182(1):19–25CrossRefPubMed Matta J, Wiernik E, Robineau O et al (2022) Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern Med 182(1):19–25CrossRefPubMed
9.
Zurück zum Zitat Mahar I, Bambico FR, Mechawar N, Nobrega JN (2014) Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neurosci Biobehav Rev 38:173–192CrossRefPubMed Mahar I, Bambico FR, Mechawar N, Nobrega JN (2014) Stress, serotonin, and hippocampal neurogenesis in relation to depression and antidepressant effects. Neurosci Biobehav Rev 38:173–192CrossRefPubMed
Metadaten
Titel
Serotonin deficiency and psychiatric long COVID: both caused specifically by the virus itself or an adaptive general stress response?
verfasst von
Udo Bonnet
Jens Kuhn
Publikationsdatum
27.02.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-024-01769-0

Neu im Fachgebiet Psychiatrie

„Wir wollen die Bedeutung von Gen- und Umwelteinflüssen besser verstehen“

Eine Mutation in einem einzelnen Gen kann bei Mäusen eine Art Bipolarstörung auslösen. PD Dr. Jan Deussing vom Max-Planck-Institut für Psychiatrie in München sieht in solchen Tiermodellen eine Möglichkeit, den Ursachen der Erkrankung auf den Grund zu gehen.

Suizidassistenz erhöht Suizidzahlen: Aktuelle Ergebnisse der geplanten S3-Leitlinie

Erstmals wird in Deutschland eine S3-Leitlinie zum Thema Suizidalität erarbeitet. Ziel ist es, die Versorgung in suizidalen Krisen durch einheitliche Standards zu verbessern. Erste Ergebnisse der bisherigen Leitlinienarbeit wurden auf dem DGPPN-Kongress vorgestellt.

Einer von sieben Frauen macht die Menopause sehr zu schaffen

Von mäßigen bis schweren vasomotorischen Beschwerden sind 14,7% der Frauen in der Postmenopause betroffen. Das haben kanadische Forscherinnen in einer Subgruppenanalyse der WARM-Studie herausgefunden.

Depressive Senioren fahren besonders riskant

Beim Autofahren machen ältere Depressive häufiger eine Vollbremsung, gehen öfter zu schnell in Kurven und halten sich seltener an Tempolimits als Senioren ohne Depression. Offenbar scheint eine Depression eine riskante Fahrweise im Alter zu verstärken.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.